51
10/14/2015 1 The Eye The Window to the Body Craig Cassidy D.O. Phoenix DISCLOSURES: NONE

The Eye the window to the body 10.7.2015 · HORDEOLUM / CHALAZION TREATMENT ... Microsoft PowerPoint - The Eye the window to the body 10.7.2015.pptx Author: jweigel Created Date:

Embed Size (px)

Citation preview

10/14/2015

1

The EyeThe Window to the Body

Craig Cassidy D.O.

Phoenix

DISCLOSURES: 

NONE

10/14/2015

2

OCULAR MANIFESTATION

SYSTEMIC DISEASE

CATEGORIES OF SYSTEMIC DISEASE

Congenital Traumatic Vascular Neoplastic Autoimmune

Idiopathic Infectious Metabolic/Endocrine Drugs/Toxins

10/14/2015

3

CONGENITAL DISORDERS

Down Syndrome Marfan Syndrome Myotonic Dystrophy Tuberous Sclerosis Congenital Metabolic Disorders

• Lysosomal Storage• Carbohydrate Metabolism

Neurofibromatosis

HYPERTENSION: FACTORS AFFECTING RETINAL ARTERIOLES

Severity Duration

10/14/2015

4

HYPERTENSIVE RETINOPATHY SYMPTOMS

Symptoms: Blurred Vision

**May cause occlusion of retinal artery or vein**

10/14/2015

5

INTRACRANIAL HYPERTENSION:CAUSES

Brain Tumor Meningitis Venous Sinus Thrombosis Hydrocephalus Idiopathic Intracranial Hypertension

10/14/2015

6

AMAUROSIS FUGAX

Monocular Dimming of Vision Temporary Arterial Obstruction Sudden, Transient, Painless Visual Loss

10/14/2015

7

AMAUROSIS FUGAX: EVALUATION

Cardiovascular Cerebrovascular Ophthalmologic

10/14/2015

8

10/14/2015

9

CENTRAL RETINAL ARTERY OCCLUSION: MANAGEMENT

Rebreathing CO2 Topical Beta Blockers Intravenous Acetazolamide 500mg Massaging of Globe with lids closed Anterior Chamber Paracentesis Calcium Channel Blockers Hyperbaric O2

10/14/2015

10

BLOOD DYSCRASIAS WITH OCULAR MANIFESTATIONS

Hyperviscosity Syndrome Thrombocytopenia Anemia, including Sickle Cell Anemia

HYPERVISCOSITY SYNDROMES: OCULAR SYMPTOMS

Amaurosis Fugax Permanent Visual Loss

10/14/2015

11

10/14/2015

12

SICKLE CELL RETINOPATHY

HbSC Disease (most common form) HbSS Disease Sickle Thalassemia

10/14/2015

13

MALIGNANT NEOPLASMS INVOLVING THE EYE

Primary Ocular Melanoma Large Cell Lymphoma Metastatic Carcinoma

10/14/2015

14

METASTATIC CARCINOMA

Most common intraocular malignancy in adults May be asymptomatic May produce decreased or distorted vision

10/14/2015

15

OCULAR METASTASIS: TREATMENT

Local radiation Chemotherapy Eye wall resection Enucleation if blind, painful eye

10/14/2015

16

AUTOIMMUNE DISORDERS

Connective tissue diseases Thyroid eye disease Myasthenia gravis

CONNECTIVE TISSUE DISORDERS

Dry eyes are the most common manifestation. Symptoms:

• Burning• Foreign Body Sensation• Photophobia

10/14/2015

17

SJÖRGRENS SYNDROME

Dry eyes Dry mouth ±Connective tissue disorder Specific antibodies

DRY EYES: TREATMENT

Artificial tears Lubricating ointment at night Punctal occlusion Restasis (Cyclosporine) Mild Topical Steroids Environmental modification

10/14/2015

18

RHEUMATOID ARTHRITIS: OCULAR MANIFESTATIONS

Dry eyes Episcleritis Scleritis Corneal ulcers Uveitis

10/14/2015

19

10/14/2015

20

10/14/2015

21

SYSTEMIC LUPUS ERYTHEMATOSUS: OCULAR MANIFESTATIONS

Dry eyes Scleritis Peripheral corneal ulcers Retinopathy and optic neuropathy

10/14/2015

22

10/14/2015

23

GIANT CELL ARTERITIS: SYMPTOMS

Headache Scalp tenderness Jaw claudication Polymyalgia rheumatica Acute visual loss

10/14/2015

24

GIANT CELL ARTERITIS: DIAGNOSIS

Clinical history STAT ESR, CRP Fluorescein angiogram Temporal artery biopsy

10/14/2015

25

If GCA is suspected, begin treatment immediately with high-dose corticosteroids daily

Do not wait for results of temporal artery biopsy

THYROID OPHTHALMOPATHY

Not always correlated with serum thyroid levels Can progress after thyroid function is normal

10/14/2015

26

THYROID OPHTHALMOPATHY: CLASSES

1. No signs or symptoms2. Only signs3. Soft tissue involvement4. Proptosis5. Extraocular muscle involvement6. Corneal damage7. Sight loss

10/14/2015

27

10/14/2015

28

10/14/2015

29

THYROID OPHTHALMOPATHY: TREATMENT OF CONGESTIVE PHASE Tear subsitutes Corticosteroids Orbital irradiation or surgical decompression

THYROID OPHTHALMOPATHY: TREATMENT OF CICATRICIAL PHASE

Lid surgery Muscle surgery Orbital surgery

10/14/2015

30

MYASTHENIA GRAVIS: SYSTEMIC INVOLVEMENT

Refer suspects for neurologic evaluation

10/14/2015

31

AIDS:OCULAR MANIFESTATIONS

Dry eye Cotton-wool spots CMV retinitis Kaposi’s sarcoma (eyelid or conjunctiva)

10/14/2015

32

CMV RETINITIS:THERAPY

IV ganciclovir IV foscarnet Intravitreal ganciclovir Implantable pellets of sustained-release ganciclovir into vitreous

10/14/2015

33

SYSTEMIC MEDICATIONS

Toxic Retinopathies• Thioridazine• Chloroquine• Tamoxifen Toxic Optic Neuropathies

• Ethambutol• Isoniazid• Fluoroquinolones

PRIMARY CARE PHYSICIAN

OPHTHALMOLOGIST

10/14/2015

34

AGE-RELATED MACULAR DEGENERATION (ARMD)

Most common cause of elderly visual loss Loss of central vision Risk factors:

• Advanced age• Fair skin• Family history of ARMD• Smoking & CV disease

10/14/2015

35

TYPES OF ARMD

Atrophic (“dry”) macular degeneration• Gradual vision loss• Drusen Exudative (“wet”) macular degeneration

• Sudden vision loss• Subretinal neovascularization• Accumulation of fluid & blood

10/14/2015

36

TYPES OF ARMD

Atrophic (“dry”) ARMD Caused by aging and thinning of macular tissues when drusen are present Vision loss is usually gradual Most common form

72With AMD, drusen are seen in the retina.

10/14/2015

37

TYPES OF ARMD

Exudative (“wet”) ARMD It is caused by abnormal blood vessels forming underneath the retina These vessels leak blood/fluid and blur central vision Vision loss may be rapid and severe

Age-Related Macular DegenerationWith wet AMD, abnormal blood vessels are present under the retina.

10/14/2015

38

ARMD: SYMPTOMS

Early• Difficulty reading, driving, etc.• Straight lines may be crooked Advanced: central blind spot Peripheral vision remains

• Independent living skills

10/14/2015

39

ARMD: MINIMIZING EFFECTS

Monitor vision with Amsler grid Stop smoking Control cardiovascular disease Diet high in fruits & vegetables lowers risk Antioxidants from food may be helpful

DIABETIC RETINOPATHY (DR)

Fourth most common cause of visual loss in elderly Type II diabetes more likely in elderly Macular edema more common with type II

10/14/2015

40

10/14/2015

41

DR: MINIMIZING EFFECTS

PCP and ophthalmologist work together Good glycemic control

• Type I: insulin• Type II: diet, exercise, weight loss

CRANIAL NERVE PALSIES

Systemic ischemic disease can lead to palsies Cranial nerves III, IV, & VI control extraocular movements PCP & ophthalmologist manage together

10/14/2015

42

10/14/2015

43

What is the Diagnosis?

10/14/2015

44

ENTROPION

Inward turning of eyelid Treatment is referral for surgery

10/14/2015

45

ECTROPION

Outward turning of eyelid Treatment is referral for surgery

10/14/2015

46

INFLAMED PINGUECULA & PTERYGIUM: MANAGEMENT

Artificial tears Topical vasoconstrictors If severe – refer

10/14/2015

47

10/14/2015

48

HORDEOLUM / CHALAZION TREATMENT

Warm compresses TID Topical antibiotics Gram positive coverage Drops for lower lid Ointment for upper lid

10/14/2015

49

RETINAL DETACHMENT

Floaters Flashes of light “Curtain” or “Veil”peripherally Vision may be decreased

10/14/2015

50

10/14/2015

51